Zobrazeno 1 - 10
of 677
pro vyhledávání: '"Isao, MATSUMOTO"'
Autor:
Kentaro Miyazaki, MD, Isao Matsumoto, MD, PhD, Satoshi Nishikawa, MD, Takashi Wada, MD, Tetsuya Takayama, MD, Daisuke Saito, MD, PhD, Shuhei Yoshida, MD, PhD, Kenji Iino, MD, PhD, Hirofumi Takemura, MD, PhD
Publikováno v:
Annals of Thoracic Surgery Short Reports, Vol 2, Iss 3, Pp 484-487 (2024)
Pulmonary artery intimal sarcoma has very poor prognosis, for which radical resection may be difficult. A 68-year-old man with pulmonary artery intimal sarcoma underwent bilateral pulmonary artery resection and replacement. At 31 months postoperative
Externí odkaz:
https://doaj.org/article/bb2581f315c04b8891a1baa2f15a8e39
Autor:
Hayato Koba, Taro Yoneda, Hiroko Morita, Hideharu Kimura, Yuya Murase, Nanao Terada, Yuichi Tambo, Masafumi Horie, Kazuo Kasahara, Isao Matsumoto, Seiji Yano
Publikováno v:
Thoracic Cancer, Vol 15, Iss 8, Pp 661-666 (2024)
Abstract Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) is crucial for patients with lung cancer harboring EGFR mutations. However, almost all patients experience disease progression, regardless of their response to the targe
Externí odkaz:
https://doaj.org/article/af7ce787e5bc4d3ebe70309ad5c2ea41
Autor:
Hiroaki Kanemura, MD, MPH, PhD, Toshihide Yokoyama, MD, Ryu Nakajima, MD, PhD, Atsushi Nakamura, MD, PhD, Hiroaki Kuroda, MD, PhD, Yoshitaka Kitamura, MD, PhD, Hiroyasu Shoda, MD, PhD, Nobuaki Mamesaya, MD, PhD, Yoshihiro Miyata, MD, PhD, Tatsuro Okamoto, MD, PhD, Kyoichi Okishio, MD, PhD, Masahide Oki, MD, PhD, Yuichi Sakairi, MD, PhD, Toyofumi Fengshi Chen-Yoshikawa, MD, PhD, Tadashi Aoki, MD, Tatsuo Ohira, MD, PhD, Isao Matsumoto, MD, PhD, Kiyonobu Ueno, MD, PhD, Takuro Miyazaki, MD, PhD, Haruhisa Matsuguma, MD, PhD, Hideoki Yokouchi, MD, PhD, Tomoyuki Otani, MD, Akihiko Ito, MD, PhD, Kazuko Sakai, PhD, Yasutaka Chiba, PhD, Kazuto Nishio, MD, PhD, Nobuyuki Yamamoto, MD, PhD, Isamu Okamoto, MD, PhD, Kazuhiko Nakagawa, MD, PhD, Masayuki Takeda, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 5, Iss 4, Pp 100658- (2024)
Introduction: Immune checkpoint inhibitors have recently been approved for the treatment of early-stage NSCLC in the perioperative setting on the basis of phase 3 trials. However, the characteristics of such patients who are susceptible to recurrence
Externí odkaz:
https://doaj.org/article/6165423210284cf69a0cf2aac07b491b
Autor:
Yohei Asano, Norio Yamamoto, Satoru Demura, Katsuhiro Hayashi, Akihiko Takeuchi, Satoshi Kato, Shinji Miwa, Kentaro Igarashi, Takashi Higuchi, Yuta Taniguchi, Sei Morinaga, Takashi Sone, Miho Okuda, Isao Matsumoto, Seiji Yano, Hiroyuki Tsuchiya
Publikováno v:
Cancer Medicine, Vol 12, Iss 11, Pp 12425-12437 (2023)
Abstract Backgrounds Immune checkpoint inhibitors (ICIs) can significantly prolong the survival of patients with advanced non‐small‐cell lung cancer (NSCLC); however, few studies on the therapeutic effects of ICIs on bone metastases were performe
Externí odkaz:
https://doaj.org/article/43041922e9654548acc1f16902216d9f
Autor:
Masaru Suzuki, Isao Matsumoto, Masato Ishida, Yoshiharu Horie, Hideyuki Ban, Wataru Takeuchi, Shunki Nakagawa, Tohru Nakagawa, Tetsuhisa Kitamura, Shigeo Muro
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract This study compared the time profile of FEV1 after COPD diagnosis among rapid decliners, slow decliners, and sustainers in the year of COPD diagnosis. COPD subjects were identified from the annual medical checkup records of Hitachi, Ltd., em
Externí odkaz:
https://doaj.org/article/1a3610a44b15482b8c50f60d58737b4e
Publikováno v:
Respirology Case Reports, Vol 11, Iss 11, Pp n/a-n/a (2023)
Key message Endobronchial lipomas are rare; nonetheless, physicians should consider them as a differential diagnosis in patients with repeated pneumonia. Computed tomography and bronchoscopy are recommended for diagnosis. In this case, the patient's
Externí odkaz:
https://doaj.org/article/7ea75aa400304fdaa01b3ab8b15cfc22
Autor:
Yuya Kondo, Saori Abe, Hirofumi Toko, Tomoya Hirota, Hiroyuki Takahashi, Masaru Shimizu, Hisashi Noma, Hiroto Tsuboi, Isao Matsumoto, Toshiro Inaba, Takayuki Sumida
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract The aim of this study was to clarify the effect of climatic environment on the immunological features of rheumatoid arthritis (RA). Blood samples were collected from patients with RA and healthy controls (HCs), matched by age and sex, living
Externí odkaz:
https://doaj.org/article/c7f40c82d42a4963b2581f4fedf289ca
Autor:
Mizuki Yagishita, Hiroto Tsuboi, Yuki Kuroda, Tomonori Sawabe, Akira Kawashima, Fumina Kawashima, Nana Uematsu, Ryota Sato, Taihei Nishiyama, Mayu Terasaki, Hirofumi Toko, Fumika Honda, Ayako Ohyama, Saori Abe, Ayako Kitada, Haruka Miki, Shinya Hagiwara, Yuya Kondo, Takayuki Sumida, Isao Matsumoto
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-8 (2022)
Abstract Recent studies have suggested that the clinical features of elderly-onset adult-onset Still’s disease (AOSD) differ from those of young and middle-aged-onset patients, whereas the details remain unclear, and cytokine profiles of elderly-on
Externí odkaz:
https://doaj.org/article/595b3e9840a24690a52cdd696d0745d9
Autor:
Hideyasu Yamada, Isao Matsumoto, Naoyuki Makita, Yoshifumi Arita, Nobuya Hayashi, Kurena Mitsuoka, Naoki Tashiro, Nobuyuki Hizawa
Publikováno v:
Respiratory Research, Vol 23, Iss 1, Pp 1-12 (2022)
Abstract Background The benefit of prompt vs delayed treatment initiation with inhaled long-acting bronchodilators in reducing exacerbations in chronic obstructive pulmonary disease (COPD) is unclear. This study aimed to investigate if long-acting br
Externí odkaz:
https://doaj.org/article/0ab9559ba9954276bce952e61cf37595
Autor:
Takayuki Sumida, Aya Kawasaki, Hiroshi Hashimoto, Naoyuki Tsuchiya, Isao Matsumoto, Yuya Kondo, Hirofumi Amano, Naoto Tamura, Premita Ari Kusumawati, Yuka Kawamura, Makio Kusaoi, Yasuyoshi Kusanagi, Kenji Itoh, Takashi Fujimoto
Publikováno v:
RMD Open, Vol 9, Iss 2 (2023)
Objective Major histocompatibility complex strongly contributes to susceptibility to systemic lupus erythematosus (SLE). In the European populations, HLA-DRB1*03:01 and DRB1*15:01 are susceptibility alleles, but C4 locus was reported to account for t
Externí odkaz:
https://doaj.org/article/7da6d1da06454ed482299aaf0e3ef8dd